Diabetes Technology Meeting 2023.

Autor: Tian T; Diabetes Technology Society, Burlingame, CA, USA., Aaron RE; Diabetes Technology Society, Burlingame, CA, USA., DuNova AY; Diabetes Technology Society, Burlingame, CA, USA., Jendle JH; School of Medicine and Health, Institute of Medical Sciences, Örebro University, Örebro, Sweden., Kerr D; Sutter Health, Santa Barbara, CA, USA., Cengiz E; School of Medicine, University of California, San Francisco, San Francisco, CA, USA., Drincic A; University of Nebraska Medical Center, Omaha, NE, USA., Pickup JC; King's College London School of Medicine, London, UK., Chen KY; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA., Schwartz N; Medcrypt, Inc., San Diego, CA, USA., Muchmore DB; La Jolla Endo, LLC, La Jolla, CA, USA., Akturk HK; Barbara Davis Center for Diabetes, University of Colorado, Aurora, CO, USA., Levy CJ; Division of Endocrinology, Diabetes, and Metabolism, Icahn School of Medicine at Mount Sinai, New York City, NY, USA., Schmidt S; Steno Diabetes Center Copenhagen, Herlev, Denmark., Bellazzi R; Università di Pavia, Pavia, Italy., Wu AHB; University of California, San Francisco, San Francisco, CA, USA., Spanakis EK; Baltimore VA Medical Center and School of Medicine, University of Maryland, Baltimore, MD, USA., Najafi B; Baylor College of Medicine, Houston, TX, USA., Chase JG; University of Canterbury, Christchurch, New Zealand., Seley JJ; Division of Endocrinology, Diabetes & Metabolism, Weill Cornell Medicine, New York City, NY, USA., Klonoff DC; Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA.

Publikováno v: Journal of diabetes science and technology [J Diabetes Sci Technol] 2024 Sep; Vol. 18 (5), pp. 1208-1244. Date of Electronic Publication: 2024 Mar 25.

SITAgliptin for Depressive Symptoms in Type 2 Diabetes: A Feasibility Randomized Controlled Trial.

Autor: Moulton CD; From the Departments of Psychological Medicine (Moulton, Young, Rokakis, Ismail) Institute of Psychiatry, Psychology and Neuroscience; Division of Diabetes and Nutritional Sciences (Pickup), Faculty of Life Sciences and Medicine; and Department of Biostatistics (Stahl), Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom., Rokakis AS, Pickup JC, Young AH, Stahl D, Ismail K

Publikováno v: Psychosomatic medicine [Psychosom Med] 2021 Oct 01; Vol. 83 (8), pp. 913-923.

Non-invasive, continuous oral delivery of solid levodopa-carbidopa for management of Parkinson's disease.

Autor: Murch, William L.¹ (AUTHOR) murch.william@gmail.com, Spiridigliozzi, John¹ (AUTHOR), Heller, Adam¹ (AUTHOR), Heller, Ephraim¹ (AUTHOR) eheller01@gmail.com

Publikováno v: Scientific Reports. 11/5/2024, Vol. 14 Issue 1, p1-9. 9p.

Criteria for Personalised Choice of a Continuous Glucose Monitoring System: An Expert Opinion.

Autor: Di Molfetta, Sergio¹ (AUTHOR), Rossi, Antonio² (AUTHOR), Boscari, Federico³ (AUTHOR), Irace, Concetta⁴ (AUTHOR) irace@unicz.it, Laviola, Luigi¹ (AUTHOR), Bruttomesso, Daniela⁴ (AUTHOR)

Publikováno v: Diabetes Therapy. Nov2024, Vol. 15 Issue 11, p2263-2278. 16p.

Associations of cardiometabolic index with diabetic statuses and insulin resistance: the mediating role of inflammation-related indicators.

Autor: Xu, Bin^1,2 (AUTHOR), Wu, Qian^3,4 (AUTHOR) qianwujoint@163.com, Yin, Guoqing¹ (AUTHOR), Lu, Lingchen⁵ (AUTHOR), La, Rui³ (AUTHOR), Zhang, Yaxin⁶ (AUTHOR), Alifu, Jiasuer¹ (AUTHOR), Zhang, Wen¹ (AUTHOR), Guo, Fushan² (AUTHOR), Ji, Beina² (AUTHOR), Abdu, Fuad A.¹ (AUTHOR) 1691026@tongji.edu.cn, Che, Wenliang¹ (AUTHOR) chewenliang@tongji.edu.cn

Publikováno v: BMC Public Health. 10/8/2024, Vol. 24 Issue 1, p1-14. 14p.